References

Abrantes J, van der Loo W, Le Pendu J, Esteves PJ. Rabbit haemorrhagic disease (RHD) and rabbit haemorrhagic disease virus (RHDV): a review. Vet Res.. 2012; 43:(1) https://doi.org/10.1186/1297-9716-43-12

Bartrip PW. Myxomatosis in 1950s Britain. 20 Century Br Hist. 2008; 19:(1)83-105 https://doi.org/10.1093/tcbh/hwm016

Dawson S, Cooper B. Principles of infection and immunity, 6th Edition. In: Cooper B, Mullineaux E, Turner L (eds). Gloucester: British Small Animal Veterinary Association; 2020

European Medicines Agency. Nobivac Myxo-RHD. 2021. https://www.ema.europa.eu/en/medicines/veterinary/EPAR/nobivac-myxo-rhd (accessed 28 June 2022)

Infectious diseases in rabbits. VCA animal hospitals. n.d. https://vcahospitals.com/know-your-pet/rabbits-diseases (accessed 28 June 2022)

Dermatologic diseases, Third Edition. In: Hess L, Tater K. (eds). : Elsevier; 2012 https://doi.org/10.1016/B978-1-4160-6621-7.00018-X

Rabbit Hemorrhagic Disease Virus: Prevention, Biosecurity. 2020. https://www.in.gov/boah/files/Rabbit_RHDV_We-binar_6-2020.pdf (accessed 28 June 2022)

Kerr PJ. Myxomatosis in Australia and Europe: a model for emerging infectious diseases. Antiviral Res.. 2012; 93:(3)387-415 https://doi.org/10.1016/j.antiviral.2012.01.009

MSD Animal Health. Nobivac-myxo-rhd-plus-for-rabbits. Retrieved from MSD Animal Health. https://www.msd-animal-health-hub.co.uk/AHP/nobivac-myxo-rhd-plus-for-rabbits (accessed 23 September 2021)

People 's Dispensary for Sick Animals. PAW Report. 2021. https://www.pdsa.org.uk/what-we-do/pdsa-animal-wellbeing-report/paw-re-port-2021 (accessed 28 June 2022)

Rabbit Welfare Association & Fund (RWAF). Rabbits and myxomatosis. n.d. https://rabbitwelfare.co.uk/rabbit-health/disease/myxomatosis (accessed 27 June 2021)

Rabbit Welfare Association & Fund (RWAF). RVHD2 update 2017. 2017. https://rabbitwelfare.co.uk/rvhd2-update-november-2017/ (accessed 28 June 2022)

Stull JW, Brophy J, Weese J. Reducing the risk of pet-assocrated zoonotic infections. CMAJ.. 2015; 187:(10)736-743 https://doi.org/10.1503/cmaj.141020

An overview of rabbit diseases and their current vaccination protocols

02 July 2022
10 mins read
Volume 13 · Issue 6
Figure 1. Typical presentation of myxomatosis in a wild rabbit showing purulent blepharoconjunctivitis.

Abstract

Rabbits have become a popular household pet, and it is important that veterinary professionals are able to educate pet owners on their healthcare needs, and in particular on up to date vaccination protocols. The main problematic viral diseases that rabbits can be vaccinated against are of rabbit viral haemorrhagic disease (RVHD) and myxomatosis. While the original strain of RVHD, a type of calicivirus, has been present in the UK for decades, a variant of this disease first reported in France in 2010 has become a concern for many veterinary professionals and pet owners.

In 2021 there were 900 000 pet rabbits living in the UK, and 2% of adults owned a rabbit (PDSA, 2021). According to the PAW report 2021, a higher proportion had been neutered and were insured in 2021, while the proportion that have received regular boosters had decreased when compared with pre-pandemic levels (PDSA, 2021) — 50% (450 000 rabbits) are not receiving regular boosters (higher than pre-pandemic levels — 42% in February 2020). There are a number of viral diseases against which rabbits should be vaccinated, including myxomatosis and rabbit viral haemorrhagic disease (RVHD).

Myxomatosis is a disease caused by the myxoma virus that was first recognised in a laboratory in 1896 where it killed European rabbits (Oryctolagus cuniculus). It was originally introduced to wild rabbits in Australia in the 1950s as a means of managing the growing populations that were considered a pest species, and eventually spread across Europe and by 1953 Britain, rapidly killing tens of millions of animals. Many people in agricultural business and forestry, welcomed the disease as a pest control on rabbit populations. But others such as those that hunted the species for meat and fur deplored the virus as it resulted in loss of income for their business (Bartrip, 2008).

Register now to continue reading

Thank you for visiting The Veterinary Nurse and reading some of our peer-reviewed content for veterinary professionals. To continue reading this article, please register today.